{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-035864","form_type":"8-K","ticker":"FHTX","cik":"0001822462","company_name":"Foghorn Therapeutics Inc.","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.679775+00:00","generated_at":"2026-05-31T11:10:33.627236+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Foghorn reports Q2 net loss $23M; cash $285M into 2027; FHD-286 AML data Q4; FHD-909 first patient H2 2024","bullets":["Net loss $23.0M for Q2 2024 vs $29.5M in Q2 2023; collaboration revenue $6.9M.","Cash, equivalents & marketable securities $285.2M as of June 30, 2024; expected cash runway into 2027.","Topline Phase 1 data for FHD-286 + decitabine in r/r AML anticipated Q4 2024; includes safety, efficacy, PK/PD.","FHD-909 (SMARCA2 selective inhibitor) IND cleared May 2024; first patient dosing H2 2024 in SMARCA4 mutated NSCLC.","Selective CBP degrader IND-enabling studies on track to start Q4 2024; $110M financing closed May 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-035864","json":"https://secwatch.observer/filing/0001628280-24-035864.json","markdown":"https://secwatch.observer/filing/0001628280-24-035864.md","text":"https://secwatch.observer/filing/0001628280-24-035864.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822462/000162828024035864/0001628280-24-035864-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822462/000162828024035864/fhtx-20240808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:10:33.627236+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}